Sexual Dimorphism in Neurodegenerative Diseases and in Brain Ischemia
暂无分享,去创建一个
[1] L. Gan,et al. X-linked ubiquitin-specific peptidase 11 increases tauopathy vulnerability in women , 2022, Cell.
[2] Sterling C. Johnson,et al. An IL1RL1 genetic variant lowers soluble ST2 levels and the risk effects of APOE-ε4 in female patients with Alzheimer’s disease , 2022, Nature Aging.
[3] V. Haroutunian,et al. FSH blockade improves cognition in mice with Alzheimer’s disease , 2022, Nature.
[4] Yafu Yin,et al. Microglia Polarization From M1 to M2 in Neurodegenerative Diseases , 2022, Frontiers in Aging Neuroscience.
[5] L. Gan,et al. Sex Differences in Neurodegeneration: The Role of the Immune System in Humans , 2021, Biological Psychiatry.
[6] K. Lunetta,et al. Genome‐wide association and multi‐omics studies identify MGMT as a novel risk gene for Alzheimer disease among women , 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.
[7] Jose A. Santiago,et al. Network Analysis Identifies Sex-Specific Gene Expression Changes in Blood of Amyotrophic Lateral Sclerosis Patients , 2021, International journal of molecular sciences.
[8] N. Rocha,et al. Sex Differences in Huntington's Disease: Evaluating the Enroll‐HD Database , 2021, Movement disorders clinical practice.
[9] Stephen A. Goutman,et al. Amyotrophic Lateral Sclerosis Survival Associates With Neutrophils in a Sex-specific Manner , 2021, Neurology: Neuroimmunology & Neuroinflammation.
[10] R. Velazquez,et al. Sex differences in the IntelliCage and the Morris water maze in the APP/PS1 mouse model of amyloidosis , 2021, Neurobiology of Aging.
[11] C. Wahlestedt,et al. Sexual Dimorphism in the 3xTg-AD Mouse Model and Its Impact on Pre-Clinical Research , 2021, Journal of Alzheimer's disease : JAD.
[12] A. Nunomura,et al. RNA and Oxidative Stress in Alzheimer's Disease: Focus on microRNAs , 2020, Oxidative medicine and cellular longevity.
[13] Cassandra E. Meyer,et al. Sex differences in brain atrophy in multiple sclerosis , 2020, Biology of sex differences.
[14] Julie A. Harris,et al. A second X chromosome contributes to resilience in a mouse model of Alzheimer’s disease , 2020, Science Translational Medicine.
[15] D. Hernandez,et al. Differences in the Presentation and Progression of Parkinson's Disease by Sex , 2020, medRxiv.
[16] J. Grose,et al. The effects of diet and sex in amyotrophic lateral sclerosis. , 2020, Revue neurologique.
[17] Filip Kosel,et al. Behavioural and psychological symptoms of dementia in mouse models of Alzheimer’s disease-related pathology , 2020, Neuroscience & Biobehavioral Reviews.
[18] E. Moro,et al. Sex differences in movement disorders , 2020, Nature Reviews Neurology.
[19] Lei Li,et al. Zerumbone ameliorates behavioral impairments and neuropathology in transgenic APP/PS1 mice by suppressing MAPK signaling , 2019, Journal of Neuroinflammation.
[20] Yue-Ming Li,et al. Friend, Foe or Both? Immune Activity in Alzheimer’s Disease , 2019, Front. Aging Neurosci..
[21] H. Bramlett,et al. Sexually dimorphic microglia and ischemic stroke , 2019, CNS neuroscience & therapeutics.
[22] Joohyung Lee,et al. Sex-specific neuroprotection by inhibition of the Y-chromosome gene, SRY, in experimental Parkinson’s disease , 2019, Proceedings of the National Academy of Sciences.
[23] James H. Faghmous,et al. Huntington's disease in the United States: Variation by demographic and socioeconomic factors , 2019, Movement disorders : official journal of the Movement Disorder Society.
[24] Keith A. Johnson,et al. Sex Differences in the Association of Global Amyloid and Regional Tau Deposition Measured by Positron Emission Tomography in Clinically Normal Older Adults , 2019, JAMA neurology.
[25] Y. Ouyang,et al. Elucidating sex differences in response to cerebral ischemia: immunoregulatory mechanisms and the role of microRNAs , 2019, Progress in Neurobiology.
[26] Nicola Thrupp,et al. The Major Risk Factors for Alzheimer’s Disease: Age, Sex, and Genes Modulate the Microglia Response to Aβ Plaques , 2019, Cell reports.
[27] G. Manfredi,et al. Sex Differences in Ischemia/Reperfusion Injury: The Role of Mitochondrial Permeability Transition , 2019, Neurochemical Research.
[28] A. Chiò,et al. Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials , 2019, Neurology.
[29] J. Kriz,et al. Brain Response to Injuries: When Microglia Go Sexist , 2019, Neuroscience.
[30] S. Gold,et al. Sex differences in autoimmune disorders of the central nervous system , 2018, Seminars in Immunopathology.
[31] D. Bennett,et al. Sex differences in Alzheimer’s disease and common neuropathologies of aging , 2018, Acta Neuropathologica.
[32] L. McCullough,et al. Sex differences in stroke: Challenges and opportunities , 2018, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[33] Sterling C. Johnson,et al. Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau , 2018, JAMA neurology.
[34] N. Pedersen,et al. Differences Between Women and Men in Incidence Rates of Dementia and Alzheimer's Disease. , 2018, Journal of Alzheimer's disease : JAD.
[35] Sterling C. Johnson,et al. Sex-specific genetic predictors of Alzheimer’s disease biomarkers , 2018, Acta Neuropathologica.
[36] K. Lenz,et al. Microglia and Beyond: Innate Immune Cells As Regulators of Brain Development and Behavioral Function , 2018, Front. Immunol..
[37] A. Bentivoglio,et al. The contribution of gender differences in motor, behavioral and cognitive features to functional capacity, independence and quality of life in patients with Huntington's disease. , 2018, Parkinsonism & related disorders.
[38] J. Matysik,et al. Sex- and age-specific modulation of brain GABA levels in a mouse model of Alzheimer's disease , 2018, Neurobiology of Aging.
[39] R. Voskuhl,et al. Oestrogen receptor β ligand acts on CD11c+ cells to mediate protection in experimental autoimmune encephalomyelitis , 2017, Brain : a journal of neurology.
[40] R. Villa,et al. Post‐stroke depression: Mechanisms and pharmacological treatment , 2017, Pharmacology & therapeutics.
[41] L. Garcia-Segura,et al. Sex differences in Parkinson’s disease: Features on clinical symptoms, treatment outcome, sexual hormones and genetics , 2017, Frontiers in Neuroendocrinology.
[42] M. Mielke. Sex and Gender Differences in Alzheimer's Disease Dementia. , 2018, The Psychiatric times.
[43] L. Mosconi,et al. Female Sex and Alzheimer’s Risk: The Menopause Connection , 2018, The Journal of Prevention of Alzheimer's Disease.
[44] C. Angelini,et al. Micro-RNAs in ALS muscle: Differences in gender, age at onset and disease duration , 2017, Journal of the Neurological Sciences.
[45] R. Gold,et al. Testosterone Differentially Affects T Cells and Neurons in Murine and Human Models of Neuroinflammation and Neurodegeneration. , 2017, The American journal of pathology.
[46] K. Suk,et al. Pharmacological Modulation of Functional Phenotypes of Microglia in Neurodegenerative Diseases , 2017, Front. Aging Neurosci..
[47] Natalie V. Motta-Mena,et al. Endocrinology of human female sexuality, mating, and reproductive behavior , 2017, Hormones and Behavior.
[48] M. Colonna,et al. Microglia Function in the Central Nervous System During Health and Neurodegeneration. , 2017, Annual review of immunology.
[49] L. McCullough,et al. Sex differences in ischaemic stroke: potential cellular mechanisms. , 2017, Clinical science.
[50] A. ElAli,et al. Complex Roles of Microglial Cells in Ischemic Stroke Pathobiology: New Insights and Future Directions , 2017, International journal of molecular sciences.
[51] L. McCullough,et al. Sex differences in neuroinflammation and neuroprotection in ischemic stroke , 2017, Journal of neuroscience research.
[52] S. Weis,et al. Sex‐dependent consequences of neonatal brain hypoxia‐ischemia in the rat , 2017, Journal of neuroscience research.
[53] P. Libby,et al. The Aging Cardiovascular System , 2017 .
[54] E. Glaab,et al. Gender-Specific Expression of Ubiquitin-Specific Peptidase 9 Modulates Tau Expression and Phosphorylation: Possible Implications for Tauopathies , 2016, Molecular Neurobiology.
[55] Tao Wu,et al. The study of brain functional connectivity in Parkinson’s disease , 2016, Translational Neurodegeneration.
[56] R. Prediger,et al. Melatoninergic System in Parkinson's Disease: From Neuroprotection to the Management of Motor and Nonmotor Symptoms , 2016, Oxidative medicine and cellular longevity.
[57] S. Klein,et al. Sex differences in immune responses , 2016, Nature Reviews Immunology.
[58] S. Gold,et al. Sex effects on inflammatory and neurodegenerative processes in multiple sclerosis , 2016, Neuroscience & Biobehavioral Reviews.
[59] C. Pike,et al. Obesity and sex interact in the regulation of Alzheimer's disease , 2016, Neuroscience & Biobehavioral Reviews.
[60] M. Morissette,et al. Neuroactive gonadal drugs for neuroprotection in male and female models of Parkinson's disease , 2016, Neuroscience & Biobehavioral Reviews.
[61] C. Gibson,et al. The impact of gender on stroke pathology and treatment , 2016, Neuroscience & Biobehavioral Reviews.
[62] G. Panzica,et al. Structural and molecular brain sexual differences: A tool to understand sex differences in health and disease , 2016, Neuroscience & Biobehavioral Reviews.
[63] Lin Yin,et al. Neuroprotective effect of angiotensin II type 2 receptor during cerebral ischemia/reperfusion , 2016, Neural regeneration research.
[64] L. McCullough,et al. Stroke sensitivity in the aged: sex chromosome complement vs. gonadal hormones , 2016, Aging.
[65] T. Drake,et al. Sex differences and hormonal effects on gut microbiota composition in mice , 2016, Gut microbes.
[66] H. Shill,et al. Gender Differences in Alzheimer Disease: Brain Atrophy, Histopathology Burden, and Cognition , 2016, Journal of neuropathology and experimental neurology.
[67] Paul M. Thompson,et al. Age, APOE and sex: Triad of risk of Alzheimer’s disease , 2016, The Journal of Steroid Biochemistry and Molecular Biology.
[68] G. Fiskum,et al. Sex‐dependent mitochondrial respiratory impairment and oxidative stress in a rat model of neonatal hypoxic‐ischemic encephalopathy , 2016, Journal of neurochemistry.
[69] N. Jetté,et al. The Incidence of Parkinson's Disease: A Systematic Review and Meta-Analysis , 2016, Neuroepidemiology.
[70] M. Lalancette-Hébert,et al. Estrogen receptors alpha mediates postischemic inflammation in chronically estrogen-deprived mice , 2016, Neurobiology of Aging.
[71] J. Chao,et al. iNOS Induces Vascular Endothelial Cell Migration and Apoptosis Via Autophagy in Ischemia/Reperfusion Injury , 2016, Cellular Physiology and Biochemistry.
[72] J. Hardy,et al. The amyloid hypothesis of Alzheimer's disease at 25 years , 2016, EMBO molecular medicine.
[73] Xiongwei Zhu,et al. Estrogen receptor-α is localized to neurofibrillary tangles in Alzheimer’s disease , 2016, Scientific Reports.
[74] Angela M. Malek,et al. The epidemiology of amyotrophic lateral sclerosis. , 2016, Handbook of clinical neurology.
[75] P. Preux,et al. Epidemiology of amyotrophic lateral sclerosis: A review of literature. , 2016, Revue neurologique.
[76] S. Shimozaki,et al. Disease stage, but not sex, predicts depression and psychological distress in Huntington's disease: A European population study. , 2016, Journal of psychosomatic research.
[77] Sara Zarei,et al. A comprehensive review of amyotrophic lateral sclerosis , 2015, Surgical neurology international.
[78] Richard E. Brown,et al. The problem of genotype and sex differences in life expectancy in transgenic AD mice , 2015, Neuroscience & Biobehavioral Reviews.
[79] Joohyung Lee,et al. Biological factors underlying sex differences in neurological disorders. , 2015, The international journal of biochemistry & cell biology.
[80] N. Sharma,et al. Characterization of the lipopolysaccharide induced model of Parkinson's disease: Role of oxidative stress and neuroinflammation , 2015, Neurochemistry International.
[81] R. Giffard,et al. IL-4 Is Required for Sex Differences in Vulnerability to Focal Ischemia in Mice , 2015, Stroke.
[82] M. McCarthy,et al. A Starring Role for Microglia in Brain Sex Differences , 2015, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[83] S. Mitra,et al. Gender-specific brain regional variation of neurons, endogenous estrogen, neuroinflammation and glial cells during rotenone-induced mouse model of Parkinson’s disease , 2015, Neuroscience.
[84] R. Rigolio,et al. Dihydrotestosterone as a Protective Agent in Chronic Experimental Autoimmune Encephalomyelitis , 2015, Neuroendocrinology.
[85] Susan Kovats,et al. Estrogen receptors regulate innate immune cells and signaling pathways , 2015, Cellular immunology.
[86] You Li,et al. MiR-206, a Key Modulator of Skeletal Muscle Development and Disease , 2015, International journal of biological sciences.
[87] A. Arnold,et al. Sex Differences in Ischemic Stroke Sensitivity Are Influenced by Gonadal Hormones, Not by Sex Chromosome Complement , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[88] B. Trapp,et al. Pathological mechanisms in progressive multiple sclerosis , 2015, The Lancet Neurology.
[89] M. Schumacher,et al. Progesterone and nestorone promote myelin regeneration in chronic demyelinating lesions of corpus callosum and cerebral cortex , 2015, Glia.
[90] Ornella Rimoldi,et al. Coronary microvascular dysfunction: mechanisms and functional assessment , 2015, Nature Reviews Cardiology.
[91] S. Appel,et al. Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis , 2015, Neurotherapeutics.
[92] J. Katzenellenbogen,et al. Multiple functional therapeutic effects of the estrogen receptor β agonist indazole-Cl in a mouse model of multiple sclerosis , 2014, Proceedings of the National Academy of Sciences.
[93] M. Schumacher,et al. cacy of the selective progesterone receptor agonist Nestorone for chronic experimental autoimmune encephalomyelitis , 2014 .
[94] A. Yoshimura,et al. Post-ischemic inflammation regulates neural damage and protection , 2014, Front. Cell. Neurosci..
[95] Kara M. Smith,et al. Sex differences in Parkinson's disease and other movement disorders , 2014, Experimental Neurology.
[96] K. Bertram,et al. Sex differences in Parkinson’s disease , 2014, Journal of Clinical Neuroscience.
[97] G. Gillies,et al. Sex differences in Parkinson’s disease , 2014, Frontiers in Neuroendocrinology.
[98] Rena Li,et al. Sex differences in cognitive impairment and Alzheimer’s disease , 2014, Frontiers in Neuroendocrinology.
[99] P. Mccombe,et al. Gender differences in autoimmune disease , 2014, Frontiers in Neuroendocrinology.
[100] F. Sohrabji,et al. Circulating miRNA profiles provide a biomarker for severity of stroke outcomes associated with age and sex in a rat model. , 2014, Clinical science.
[101] D. Brites,et al. Microglia centered pathogenesis in ALS: insights in cell interconnectivity , 2014, Front. Cell. Neurosci..
[102] E. Giltay,et al. Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY) , 2014, Journal of Neurology, Neurosurgery & Psychiatry.
[103] J. Correale. The role of microglial activation in disease progression , 2014, Multiple sclerosis.
[104] R. D. Du Pasquier,et al. Immunological Mechanism of Action and Clinical Profile of Disease-Modifying Treatments in Multiple Sclerosis , 2014, CNS Drugs.
[105] Andre Altmann,et al. Sex modifies the APOE‐related risk of developing Alzheimer disease , 2014, Annals of neurology.
[106] E. Fish,et al. SeXX matters in immunity. , 2014, Trends in immunology.
[107] T. Chitnis,et al. The role of gender and sex hormones in determining the onset and outcome of multiple sclerosis , 2014, Multiple sclerosis.
[108] P. Ostadal,et al. Sex‐based differences in cardiac ischaemic injury and protection: therapeutic implications , 2014, British journal of pharmacology.
[109] S. Soyal,et al. A single nucleotide polymorphism in the coding region of PGC-1α is a male-specific modifier of Huntington disease age-at-onset in a large European cohort , 2014, BMC Neurology.
[110] A. Churchyard,et al. Aggression in Huntington's disease: a systematic review of rates of aggression and treatment methods. , 2014, Journal of Huntington's disease.
[111] S. Kumar,et al. Estrogen receptor (ER) β expression in oligodendrocytes is required for attenuation of clinical disease by an ERβ ligand , 2013, Proceedings of the National Academy of Sciences.
[112] Jane S. Paulsen,et al. Characterization of depression in prodromal Huntington disease in the neurobiological predictors of HD (PREDICT-HD) study. , 2013, Journal of psychiatric research.
[113] Chandler R. L. Mongerson,et al. Estrogen Mediates Neuroprotection and Anti-Inflammatory Effects during EAE through ERα Signaling on Astrocytes But Not through ERβ Signaling on Astrocytes or Neurons , 2013, The Journal of Neuroscience.
[114] Shao-Hua Yang,et al. Window of opportunity: Estrogen as a treatment for ischemic stroke , 2013, Brain Research.
[115] Xiaonan H. Wang. MicroRNA in myogenesis and muscle atrophy , 2013, Current opinion in clinical nutrition and metabolic care.
[116] J. Gustafsson,et al. Targeting estrogen receptor β in microglia and T cells to treat experimental autoimmune encephalomyelitis , 2013, Proceedings of the National Academy of Sciences.
[117] C. Pike,et al. Gender, sex steroid hormones, and Alzheimer's disease , 2013, Hormones and Behavior.
[118] H. Putter,et al. The influence of gender on phenotype and disease progression in patients with Huntington's disease. , 2013, Parkinsonism & related disorders.
[119] Bartosz Bielecki,et al. The neural androgen receptor: a therapeutic target for myelin repair in chronic demyelination. , 2013, Brain : a journal of neurology.
[120] J. Veldink,et al. Endogenous female reproductive hormones and the risk of amyotrophic lateral sclerosis , 2013, Journal of Neurology.
[121] L. McCullough,et al. Interactions between age, sex, and hormones in experimental ischemic stroke , 2012, Neurochemistry International.
[122] F. Campos,et al. GDNF Contributes to Oestrogen‐Mediated Protection of Midbrain Dopaminergic Neurones , 2012, Journal of neuroendocrinology.
[123] N. Jetté,et al. The incidence and prevalence of Huntington's disease: A systematic review and meta‐analysis , 2012, Movement disorders : official journal of the Movement Disorder Society.
[124] C. Pike,et al. Evaluation of the effects of testosterone and luteinizing hormone on regulation of β-amyloid in male 3xTg-AD mice , 2012, Brain Research.
[125] A. Hannan,et al. Environmental enrichment rescues female-specific hyperactivity of the hypothalamic-pituitary-adrenal axis in a model of Huntington's disease , 2012, Translational Psychiatry.
[126] Giovanni Coppola,et al. Gender Modulates the APOE ε4 Effect in Healthy Older Adults: Convergent Evidence from Functional Brain Connectivity and Spinal Fluid Tau Levels , 2012, The Journal of Neuroscience.
[127] J. Trojanowski,et al. Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies. , 2012, Brain : a journal of neurology.
[128] A. Hannan,et al. Deficits in Spermatogenesis but not Neurogenesis are Alleviated by Chronic Testosterone Therapy in R6/1 Huntington’s Disease Mice , 2012, Journal of neuroendocrinology.
[129] E. Mufson,et al. Effects of aromatase inhibition versus gonadectomy on hippocampal complex amyloid pathology in triple transgenic mice , 2012, Neurobiology of Disease.
[130] R. Voskuhl,et al. Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration , 2012, Frontiers in Neuroendocrinology.
[131] S. Amor,et al. Multiple sclerosis: Neuroprotective alliance of estrogen–progesterone and gender , 2012, Frontiers in Neuroendocrinology.
[132] M. Tabaton,et al. Amyloid-β Production: Major Link Between Oxidative Stress and BACE1 , 2012, Neurotoxicity Research.
[133] D. Aarsland,et al. Gender-related differences in the burden of non-motor symptoms in Parkinson’s disease , 2012, Journal of Neurology.
[134] I. Tendolkar,et al. Prevalence of depression in Parkinson's disease: Effects of disease stage, motor subtype and gender , 2011, Journal of the Neurological Sciences.
[135] K. Langa,et al. Incidence of dementia and cognitive impairment, not dementia in the united states , 2011, Annals of neurology.
[136] L. Lanfumey,et al. Sexually Dimorphic Serotonergic Dysfunction in a Mouse Model of Huntington's Disease and Depression , 2011, PloS one.
[137] H. Weiner,et al. Demographic and clinical characteristics of malignant multiple sclerosis , 2011, Neurology.
[138] C. Iadecola,et al. The immunology of stroke: from mechanisms to translation , 2011, Nature Medicine.
[139] Andrew C. Li,et al. An ADIOL-ERβ-CtBP Transrepression Pathway Negatively Regulates Microglia-Mediated Inflammation , 2011, Cell.
[140] L. McCullough,et al. Estrogen Enhances Neurogenesis and Behavioral Recovery after Stroke , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[141] Pamela A McCombe,et al. Effects of gender in amyotrophic lateral sclerosis. , 2010, Gender medicine.
[142] Erik Sahai,et al. Deficits in axonal transport precede ALS symptoms in vivo , 2010, Proceedings of the National Academy of Sciences.
[143] C. Pike,et al. Testosterone regulation of Alzheimer-like neuropathology in male 3xTg-AD mice involves both estrogen and androgen pathways , 2010, Brain Research.
[144] Bingbing Song,et al. Oestrogen receptor b ligand : a novel treatment to enhance endogenous functional remyelination , 2010 .
[145] L. Goldstein,et al. The sex ratio in amyotrophic lateral sclerosis: A population based study , 2010, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[146] R. Rozmahel,et al. Neuroprotective mechanism conferred by 17beta-estradiol on the biochemical basis of Alzheimer's disease , 2010, Neuroscience.
[147] M. Amato,et al. Cognitive impairment in early stages of multiple sclerosis , 2010, Neurological Sciences.
[148] C. Pike,et al. Continuous and cyclic progesterone differentially interact with estradiol in the regulation of Alzheimer-like pathology in female 3xTransgenic-Alzheimer's disease mice. , 2010, Endocrinology.
[149] G. Gillies,et al. Estrogen Actions in the Brain and the Basis for Differential Action in Men and Women: A Case for Sex-Specific Medicines , 2010, Pharmacological Reviews.
[150] F. Gonzalez-Lima,et al. Pre-symptomatic detection of chronic motor deficits and genotype prediction in congenic B6.SOD1 G93A ALS mouse model , 2009, Neuroscience.
[151] John McAnally,et al. MicroRNA-206 Delays ALS Progression and Promotes Regeneration of Neuromuscular Synapses in Mice , 2009, Science.
[152] C. Colton. Heterogeneity of Microglial Activation in the Innate Immune Response in the Brain , 2009, Journal of Neuroimmune Pharmacology.
[153] Cristian Sirbu,et al. Testosterone and Depression: Systematic Review and Meta-Analysis , 2009, Journal of psychiatric practice.
[154] K. Ono,et al. Anti-aggregation and fibril-destabilizing effects of sex hormones on α-synuclein fibrils in vitro , 2009, Experimental Neurology.
[155] Ludovico Minati,et al. Reviews: Current Concepts in Alzheimer's Disease: A Multidisciplinary Review , 2009, American journal of Alzheimer's disease and other dementias.
[156] T. Toung,et al. Age-Dependent Effects of Testosterone in Experimental Stroke , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[157] S. Çitak,et al. Do different delivery systems of hormone therapy have different effects on psychological symptoms in surgically menopausal women? A randomized controlled trial. , 2009, Maturitas.
[158] A. Hannan,et al. Altered serotonin receptor expression is associated with depression-related behavior in the R6/1 transgenic mouse model of Huntington's disease. , 2009, Human molecular genetics.
[159] L. McCullough,et al. Sex Differences in Minocycline-Induced Neuroprotection after Experimental Stroke , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[160] J. Studd,et al. Are oestrogens useful for the treatment of depression in women? , 2009, Best practice & research. Clinical obstetrics & gynaecology.
[161] H. Fullerton,et al. Male Predominance in Childhood Ischemic Stroke: Findings From the International Pediatric Stroke Study , 2009, Stroke.
[162] Andreas Bauer,et al. Sex differences in a transgenic rat model of Huntington's disease: decreased 17beta-estradiol levels correlate with reduced numbers of DARPP32+ neurons in males. , 2008, Human molecular genetics.
[163] S. Callier,et al. Estrogen and SERM neuroprotection in animal models of Parkinson's disease , 2008, Molecular and Cellular Endocrinology.
[164] B. Gwag,et al. Effects of estrogen on lifespan and motor functions in female hSOD1 G93A transgenic mice , 2008, Journal of the Neurological Sciences.
[165] C. Pike,et al. Selective estrogen receptor modulators differentially regulate Alzheimer-like changes in female 3xTg-AD mice. , 2008, Endocrinology.
[166] J. Simpkins,et al. Mitochondrial mechanisms of estrogen neuroprotection , 2008, Brain Research Reviews.
[167] C. Charriaut-Marlangue,et al. Gender-Related Differences in Apoptotic Pathways After Neonatal Cerebral Ischemia , 2008, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[168] D. Reich,et al. Corticospinal Tract Abnormalities Are Associated with Weakness in Multiple Sclerosis , 2008, American Journal of Neuroradiology.
[169] Jane S. Paulsen,et al. Psychiatric Symptoms in Huntington’s Disease before Diagnosis: The Predict-HD Study , 2007, Biological Psychiatry.
[170] Adama Brown,et al. Depression in multiple sclerosis: a longitudinal analysis. , 2007, Archives of psychiatric nursing.
[171] F. Groenendaal,et al. Gender-Dependent Pathways of Hypoxia-Ischemia-Induced Cell Death and Neuroprotection in the Immature P3 Rat , 2007, Developmental Neuroscience.
[172] B. Liu,et al. OESTROGEN AND NIGROSTRIATAL DOPAMINERGIC NEURODEGENERATION: ANIMAL MODELS AND CLINICAL REPORTS OF PARKINSON'S DISEASE , 2007, Clinical and experimental pharmacology & physiology.
[173] Sara Marceglia,et al. Gender differences in patients with Parkinson's disease treated with subthalamic deep brain stimulation , 2007, Movement disorders : official journal of the Movement Disorder Society.
[174] M. Panas,et al. Plasma testosterone, dehydroepiandrosterone sulfate, and cortisol in female patients with Huntington's disease. , 2007, Neuro endocrinology letters.
[175] G. Rebec,et al. Sex differences in behavior and striatal ascorbate release in the 140 CAG knock-in mouse model of Huntington's disease , 2007, Behavioural Brain Research.
[176] F. Gage,et al. Estradiol enhances neurogenesis following ischemic stroke through estrogen receptors α and β , 2007 .
[177] L. Sklar,et al. GPR30: A G protein-coupled receptor for estrogen , 2007, Molecular and Cellular Endocrinology.
[178] L. Berliocchi,et al. Evidence to implicate early modulation of interleukin-1beta expression in the neuroprotection afforded by 17beta-estradiol in male rats undergone transient middle cerebral artery occlusion. , 2007, International review of neurobiology.
[179] Frank M LaFerla,et al. Androgens Regulate the Development of Neuropathology in a Triple Transgenic Mouse Model of Alzheimer's Disease , 2006, The Journal of Neuroscience.
[180] Bastiaan R Bloem,et al. Gender differences in Parkinson’s disease , 2006, Journal of Neurology, Neurosurgery & Psychiatry.
[181] W. Valdar,et al. Sex ratio of multiple sclerosis in Canada: a longitudinal study , 2006, The Lancet Neurology.
[182] C. Tanner,et al. Effect of Reproductive Factors and Postmenopausal Hormone Use on the Risk of Amyotrophic Lateral Sclerosis , 2006, Neuroepidemiology.
[183] C. Tirolo,et al. Estrogen, neuroinflammation and neuroprotection in Parkinson’s disease: Glia dictates resistance versus vulnerability to neurodegeneration , 2006, Neuroscience.
[184] C. Tanner,et al. Effect of reproductive factors and postmenopausal hormone use on the risk of Parkinson disease , 2005, Neurology.
[185] J. Ávila,et al. Estradiol Prevents Neural Tau Hyperphosphorylation Characteristic of Alzheimer's Disease , 2005, Annals of the New York Academy of Sciences.
[186] E. Eriksson,et al. Investigation of genes coding for inflammatory components in Parkinson's disease , 2005, Movement disorders : official journal of the Movement Disorder Society.
[187] T. Shirasawa,et al. Estrogen, Insulin, and Dietary Signals Cooperatively Regulate Longevity Signals to Enhance Resistance to Oxidative Stress in Mice* , 2005, Journal of Biological Chemistry.
[188] M. Panas,et al. Plasma testosterone in male patients with Huntington's disease: Relations to severity of illness and dementia , 2005, Annals of neurology.
[189] L. V. D. Berg,et al. Ovariectomy and 17beta-estradiol modulate disease progression of a mouse model of ALS. , 2004, Brain research.
[190] J Melke,et al. Association between the estrogen receptor beta gene and age of onset of Parkinson’s disease , 2004, Psychoneuroendocrinology.
[191] D. Dexter,et al. Sex dimorphisms in the neuroprotective effects of estrogen in an animal model of Parkinson's disease , 2004, Pharmacology Biochemistry and Behavior.
[192] H. Braak,et al. The Biphasic Relationship between Regional Brain Senile Plaque and Neurofibrillary Tangle Distributions: Modification by Age, Sex, and APOE Polymorphism , 2004, Annals of the New York Academy of Sciences.
[193] Joanne M. Smith,et al. Stroke in the female: role of biological sex and estrogen. , 2004, ILAR journal.
[194] S. Cheema,et al. Antisense peptide nucleic acid‐mediated knockdown of the p75 neurotrophin receptor delays motor neuron disease in mutant SOD1 transgenic mice , 2003, Journal of neurochemistry.
[195] M. Tarnopolsky,et al. Creatine supplementation and riluzole treatment provide similar beneficial effects in copper, zinc superoxide dismutase (G93A) transgenic mice , 2003, Neuroscience.
[196] L. McCullough,et al. Estrogen and ischemic neuroprotection: an integrated view , 2003, Trends in Endocrinology & Metabolism.
[197] Robert B Wallace,et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. , 2003, JAMA.
[198] P. Adeleine,et al. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. , 2003, Brain : a journal of neurology.
[199] C. Pike,et al. Estrogen activates protein kinase C in neurons: role in neuroprotection , 2003, Journal of neurochemistry.
[200] Wenyin Chen,et al. Estrogen attenuates tumor necrosis factor-α expression to provide ischemic neuroprotection in female rats , 2002, Neuroscience Letters.
[201] A. Herbison,et al. Sex differences in the regulation of tyrosine hydroxylase gene transcription by estrogen in the locus coeruleus of TH9-LacZ transgenic mice. , 2002, Brain research. Molecular brain research.
[202] J. Hardy,et al. The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .
[203] L. Shulman. Is there a connection between estrogen and Parkinson's disease? , 2002, Parkinsonism & related disorders.
[204] D. Schaid,et al. Case‐control study of estrogen receptor gene polymorphisms in Parkinson's disease , 2002, Movement disorders : official journal of the Movement Disorder Society.
[205] S. Asthana,et al. High-dose estradiol improves cognition for women with AD , 2001, Neurology.
[206] J. Troncoso,et al. The prevalence of the neuropathological lesions of Alzheimer’s disease is independent of race and gender , 2001, Neurobiology of Aging.
[207] Ling Wang,et al. Morphological abnormalities in the brains of estrogen receptor β knockout mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[208] T. Foroud,et al. Progression of symptoms in the early and middle stages of Huntington disease. , 2001, Archives of neurology.
[209] H C Liu,et al. Effects of estrogen on cognition, mood, and cerebral blood flow in AD , 2000, Neurology.
[210] Anthony Gamst,et al. Estrogen Replacement Therapy for Treatment of Mild to Moderate Alzheimer Disease: A Randomized Controlled Trial , 2000 .
[211] B L Miller,et al. Estrogen for Alzheimer’s disease in women , 2000, Neurology.
[212] E. Siemers,et al. Rate of functional decline in Huntington’s disease , 2000, Neurology.
[213] C. Cotman,et al. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. , 2000, JAMA.
[214] M. Owen,et al. Age of onset in Huntington disease: sex specific influence of apolipoprotein E genotype and normal CAG repeat length , 1999, Journal of medical genetics.
[215] J. O'Callaghan,et al. The Impact of Gender and Estrogen on Striatal Dopaminergic Neurotoxicity , 1998, Annals of the New York Academy of Sciences.
[216] R. Traystman,et al. Gender-linked brain injury in experimental stroke. , 1998, Stroke.
[217] R B D'Agostino,et al. Lifetime risk of dementia and Alzheimer's disease , 1997, Neurology.
[218] D. Dluzen,et al. Estrogen as a neuroprotectant against MPTP-induced neurotoxicity in C57/B1 mice. , 1996, Neurotoxicology and teratology.
[219] R. Stelzmann,et al. An english translation of alzheimer's 1907 paper, “über eine eigenartige erkankung der hirnrinde” , 1995, Clinical anatomy.
[220] Joseph B. Martin. Huntington's disease , 1984, Neurology.